Terminal Sterilization Market Trends

  • Report ID: 5730
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Terminal Sterilization Market Trends

Growth Drivers

  • Rising number of surgical procedures - Sterile tissues or objects that come into direct touch with the bloodstream including surgical gloves and tools should be sterilized utilizing terminal sterilization cycles inside stiff sterilization containers, wrappers, or primary packaging to preserve the instruments' sterility and enable them to be preserved for later use. Therefore, a rise in surgical procedures corresponds to an increase in the usage of terminal sterilization. As per estimates, more than 300 million major surgical procedures are carried each annually worldwide.
  •  Growing geriatric population - Older adults have weakened immune systems which makes them more vulnerable to infections, leading to a higher demand for terminal sterilization to ensure that medical devices are free from viable microorganisms. According to the World Health Organization (WHO), the number of individuals 60 years of age and over will reach 2.1 billion worldwide by 2050.
  • Increasing prevalence of chronic-infectious diseases - Terminal sterilization services will become more in demand as a result of the increased prevalence of autoimmune illnesses, cancer, diabetes, and infectious diseases. This is particularly true as the need for terminal sterilization will rise as the prevalence of infectious diseases like bacterial and viral infections rises. For instance, the age-standardized total diabetes prevalence is predicted to rise by over 59% globally between 2021 and 2050.
  • Surging need for vaccines - Pharmaceutical infusions and injections are terminally sterilized in an industrial setting using saturated steam at 121 °C to guarantee the absence of microbiological contaminants such as bacteria or fungi when the product is utilized.

Challenges

  • Stringent rules and regulations - The manufacturer who manufactures sterile pharmaceutical products using terminal sterilization should adhere to the standards for efficient quality recognized by the FDA, which can be demanding and costly.
  • Requirement of appropriate sterilization method - Sterilizing goods in their final container is known as terminal sterilization; however, certain containers run the risk of rupturing, distorting, or becoming unstable while being sterilized at the terminal, which may result in prolonged delays and increased expenses for producers.
  • Expensive and time-consuming procedure, which may impact overall production.

Terminal Sterilization Market: Key Insights

            Base Year

2024

            Forecast Year

2025-2037

            CAGR

10.4%

            Base Year Market Size (2024)

USD 13.06 billion

            Forecast Year Market Size (2037)

USD 47.27 billion

            Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5730
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of terminal sterilization is assessed at USD 14.15 billion.

The terminal sterilization market size was over USD 13.06 billion in 2024 and is projected to reach USD 47.27 billion by 2037, witnessing around 10.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by rising burden of HIV across the globe.

North America industry is poised to account for largest revenue share of 40% by 2037, due to growing spending in healthcare in the region.

The major players in the market include 3M, STERIS plc, ASP (Fortive), Belimed, Inc. (Metall Zug Group), Sterigenics U.S., LLC - A Sotera Health Company, Fedegari Autoclavi S.p.A., Andersen Sterilizers, Steelco S.p.A.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample